Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

The Vector Development Laboratory provides comprehensive service in the design, creation, production, and analysis of standard gene therapy. To help investigators chose the optimum vector system for ...

Swiss drugmaker Novartis has opened a new viral vector production plant in Menges, central Slovenia, following an investment ...

As these vectors progress to the next level of phase I and phase II clinical studies, it is important to establish vector purification schemes that are both amenable to large-scale production and ...

The Gene Vector Core was founded in 1997 as the Adenovirus Vector Production Core. Over the years, we have extended our expertise to other popular viral vector systems. Our core has been one of BCM ...